RBD increase non-motor symptom in Parkinson’s disease
Objective: To investigate the relationship between the RBD and other non-motor symptoms in Parkinson's disase. Background: Rapid eye movement sleep behavior disorder (RBD) is frequent…Prevalence and risk factors of orthostatic hypotension in Thai Parkinson’s disease patients
Objective: To determine the prevalence of OH and identify risk factors associated with OH in Thai PD patients. Background: Orthostatic hypotension (OH) represents one of…Prevalence and risk factors for orthostatic hypotension in early PD
Objective: To identify the prevalence of orthostatic hypotension (OH) in early Parkinson's disease (PD) and identify clinical features associated with greater postural drop in BP…Cognitive and behavioral side effects in patients treated with droxidopa for neurogenic orthostatic hypotension
Objective: To describe adverse behavioral symptoms attributed to droxidopa therapy for neurogenic orthostatic hypotension (nOH). Background: Droxidopa, a norepinephrine (NE) precursor, improves symptoms of neurogenic…Prevalence of orthostatic hypotension after a low subacute levodopa dose in patients with parkinsonism
Objective: To evaluate the prevalence of orthostatic hypotension (OH) after a low subacute levodopa (LD) dose in patients with diagnosis of Parkinson's disease (PD) or…Use of nicotine gum to treat acute low blood pressure in Parkinson’s disease
Objective: To evaluate (1) how nicotine chewing gum is tolerated (2) how nicotine chewing gum affects acute low blood pressure (BP) in Parkinson's disease (PD).…Effects of pyridostigmine bromide vs. fludrocortison in the treatment of orthostatic hypotension in Parkinson’s disease
Objective: To report results of an investigator-initiated trial to show the non-inferiority of pyridostigmine bromide (PB) vs. fludrocortisone (FC) in the treatment of symptomatic orthostatic…
- « Previous Page
- 1
- …
- 6
- 7
- 8